Nectar Lifesciences has informed that a meeting of the board of directors of the company will be held on August 09, 2012, to consider and approve the unaudited financial results of the company for the quarter ended on June 30, 2012 and the audited financial results for financial year 2011-12, balance sheet of the company as at March 31, 2012 and profit & loss accounts for the financial year ended on March 31, 2012 and matters related thereto.
Further, the board will convene the annual general meeting of members of the company for the financial year 2011-12 and matters related thereto and the recommendation of final dividend to the members of the company for financial year 2011-12 and fixing of book closure dates and matters related thereto.
The above information is a part of company's filings submitted to BSE.